Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Scientific Reports|January 8, 2025
Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant miceMarcela P Cataldi, Qi L LuJournal of Virology|June 12, 2010
Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomesMarcela P Cataldi, Douglas M McCartyNature Communications|August 29, 2018
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant miceMarcela P Cataldi, Peijuan Lu, Anthony Blaeser, et al.Journal of Neuromuscular Diseases|January 26, 2024
Break Down of the Complexity and Inconsistency Between Levels of Matriglycan and Disease Phenotype in FKRP-Related Dystroglycanopathies: A Review and Model of InterpretationQi L Lu, Molly C Holbrook, Marcela P Cataldi, et al.Molecular Therapy. Methods & Clinical Development|January 29, 2020
ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant MiceMarcela P Cataldi, Anthony Blaeser, Peijuan Lu, et al.Molecular Therapy. Methods & Clinical Development|June 23, 2016
Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene deliveryHaiyan Fu, Marcela P Cataldi, Tierra A Ware, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2023
Improved efficacy of FKRP AAV gene therapy by combination with ribitol treatment for LGMD2IMarcela P Cataldi, Charles H Vannoy, Anthony Blaeser, et al.Pageof 1